Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6. This indicates a general page update without changes to the study information.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe footer revision tag was updated from v3.6.4 to v3.6.5, indicating a new page build. No study content or data were changed.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page no longer displays the primary disease label 'Multiple myeloma'. It also removes the 'related topics' header and the 'MedlinePlus Genetics' resource link, reducing context and navigational options for readers.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, representing a minor deployment update to the page template/renderer. There is no indication of changes to the study data or visible content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now lists 'Multiple myeloma' and a related topics section including MedlinePlus Genetics, and the site's revision tag is updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision: v3.6.2 was added. The page's related topics section was pruned to remove 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.0', leaving the update focused on versioning rather than study content.SummaryDifference0.2%

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.